{"id":"profilaxis-recommended","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to the spike protein, thereby preventing the virus from entering host cells. This mechanism of action is similar to other COVID-19 vaccines, but the specific formulation and delivery method may differ.","oneSentence":"This drug targets the SARS-CoV-2 spike protein to prevent infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:23.217Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19"}]},"trialDetails":[{"nctId":"NCT06431633","phase":"PHASE3","title":"Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.","status":"RECRUITING","sponsor":"Fundación GECP","startDate":"2025-02-04","conditions":"Lung Diseases, Carcinoma, Non-Small-Cell Lung, Resectable Lung Non-Small Cell Carcinoma","enrollment":129},{"nctId":"NCT06860945","phase":"","title":"Development of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in Spain","status":"RECRUITING","sponsor":"Hospital Universitario de Valme","startDate":"2025-01-01","conditions":"Sexually Transmitted Infections (STIs), HIV, PrEP","enrollment":9000},{"nctId":"NCT03123627","phase":"PHASE3","title":"Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.","status":"COMPLETED","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2016-08-23","conditions":"Kidney Transplant Infection","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":55,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Profilaxis recommended","genericName":"Profilaxis recommended","companyName":"Maimónides Biomedical Research Institute of Córdoba","companyId":"maim-nides-biomedical-research-institute-of-c-rdoba","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the SARS-CoV-2 spike protein to prevent infection. Used for Prevention of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}